BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer

被引：0
|
作者：
F. Z. Francies
T. Wainstein
K. De Leeneer
A. Cairns
M. Murdoch
S. Nietz
H. Cubasch
B. Poppe
T. Van Maerken
B. Crombez
I. Coene
R. Kerr
J. P. Slabbert
A. Vral
A. Krause
A. Baeyens
K. B. M. Claes
机构：
[1] iThemba LABS-National Research Foundation,Department of Radiation Sciences
[2] University of the Witwatersrand,Division of Human Genetics
[3] School of Pathology,Center for Medical Genetics
[4] University of the Witwatersrand,Department of Surgery
[5] Ghent University Hospital,Batho Pele Breast Unit
[6] Charlotte Maxeke Johannesburg Academic Hospital and Donald Gordon Medical Centre,Department of Basic Medical Sciences
[7] Chris Hani Baragwanath Academic Hospital,Division of Human Genetics
[8] Ghent University,undefined
[9] National Health Laboratory Services,undefined
来源：
BMC Cancer | / 15卷
关键词：
Triple negative breast cancer; Premenopausal breast cancer; mutations; South Africa;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] BRCA1, BRCA2 and PALB2 mutations and CHEK2 c. 1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer
    Francies, F. Z.
    Wainstein, T.
    De Leeneer, K.
    Cairns, A.
    Murdoch, M.
    Nietz, S.
    Cubasch, H.
    Poppe, B.
    Van Maerken, T.
    Crombez, B.
    Coene, I.
    Kerr, R.
    Slabbert, J. P.
    Vral, A.
    Krause, A.
    Baeyens, A.
    Claes, K. B. M.
    BMC CANCER, 2015, 15
  • [2] Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer
    Woodward, Emma R.
    van Veen, Elke M.
    Forde, Claire
    Harkness, Elaine F.
    Byers, Helen J.
    Ellingford, Jamie M.
    Burghel, George J.
    Schlech, Helene
    Bowers, Naomi L.
    Wallace, Andrew J.
    Howell, Sacha J.
    Howell, Anthony
    Lalloo, Fiona
    Newman, William G.
    Smith, Miriam J.
    Gareth Evans, D.
    GENETICS IN MEDICINE, 2021, 23 (10) : 1969 - 1976
  • [3] BRCA1, BRCA2 and CHEK2 c. 1100 delC mutations in patients with double primaries of the breasts and/or ovaries
    Evans, D. Gareth
    Ahmed, Munaza
    Bayliss, Stuart
    Howard, Emma
    Lalloo, Fiona
    Wallace, Andrew
    JOURNAL OF MEDICAL GENETICS, 2010, 47 (08) : 561 - 566
  • [4] Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer
    Lukomska, Alicja
    Menkiszak, Janusz
    Gronwald, Jacek
    Tomiczek-Szwiec, Joanna
    Szwiec, Marek
    Jasiowka, Marek
    Blecharz, Pawel
    Kluz, Tomasz
    Stawicka-Nielacna, Malgorzata
    Madry, Radoslaw
    Bialkowska, Katarzyna
    Prajzendanc, Karolina
    Kluzniak, Wojciech
    Cybulski, Cezary
    Debniak, Tadeusz
    Huzarski, Tomasz
    Toloczko-Grabarek, Aleksandra
    Byrski, Tomasz
    Baszuk, Piotr
    Narod, Steven A.
    Lubinski, Jan
    Jakubowska, Anna
    CANCERS, 2021, 13 (04) : 1 - 11
  • [5] Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
    Meijers-Heijboer, H
    van den Ouweland, A
    Klijn, J
    Wasielewski, M
    de Snoo, A
    Oldenburg, R
    Hollestelle, A
    Houben, M
    Crepin, E
    van Veghel-Plandsoen, M
    Elstrodt, F
    van Duijn, C
    Bartels, C
    Meijers, C
    Schutte, M
    McGuffog, L
    Thompson, D
    Easton, DF
    Sodha, N
    Seal, S
    Barfoot, R
    Mangion, J
    Chang-Claude, J
    Eccles, D
    Eeles, R
    Evans, DG
    Houlston, R
    Murday, V
    Narod, S
    Peretz, T
    Peto, J
    Phelan, C
    Zhang, HX
    Szabo, C
    Devilee, P
    Goldgar, D
    Futreal, PA
    Nathanson, KL
    Weber, BL
    Rahman, N
    Stratton, MR
    NATURE GENETICS, 2002, 31 (01) : 55 - 59
  • [6] Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
    Nature Genetics, 2002, 31 : 55 - 59
  • [7] Frequency of large rearrangements in BRCA1, BRCA2, ATM, CHEK2, and PALB2 in hereditary cancer testing
    Bissonnette, J.
    Doonanco, K.
    Xu, Z.
    Klein, R. T.
    Hruska, K. S.
    CANCER RESEARCH, 2016, 76
  • [8] The CHEK2 1100delC mutation is not present in Korean patients with breast cancer tested for BRCA1 and BRCA2 mutation
    Choi, D. H.
    Cho, H. Y.
    Lee, M. H.
    Park, H. S.
    Ahn, S. H.
    Haffty, B. G.
    BREAST, 2007, 16 : S14 - S14
  • [9] Mutation screening of BRCA1, BRCA2 and CHEK2*1100delC in Slovak HBOC families
    Cierniková, S
    Tomka, M
    Kovac, M
    Stevurkova, V
    Bella, V
    Novotny, J
    Zajac, V
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2): : S17 - S17
  • [10] Bilateral breast cancer - clinical features and BRCA1, BRCA2, CHEK2 mutations
    Niwinska, A.
    Jaczewska, S.
    Sienkiewicz-Kozlowska, R.
    Skasko, E.
    Balabas, A.
    Kluska, A.
    Piatkowska, M.
    Pienkowski, T.
    EJC SUPPLEMENTS, 2005, 3 (02): : 85 - 86
12345